鞍区/鞍旁病变微创入路普及中的地域差异
该研究通过在线匿名结构化问卷调查全球261名医生对鼻内镜入路(EEA)、扩大EEA及眶周入路治疗鞍区、鞍上及鞍旁病变的使用情况,发现EEA培训虽覆盖多数国家,但用于巨大垂体腺瘤、颅咽管瘤和脊索瘤的比例仍低,且使用频率存在地域差异。
要点
- 195名(74.71%)受访者接受过EEA培训,但不足半数在住院医师期间接受培训。
- 欧洲和南美洲约一半时间依赖EEA,北美和亚洲仅三分之一时间使用,非洲几乎不用。
- EEA用于巨大垂体腺瘤、嗅沟脑膜瘤、颅咽管瘤、脊索瘤、鞍结节脑膜瘤和恶性颅底肿瘤超过50%病例的比例分别为34.5%、3.4%、13%、16%、7%和10%。
核心结论
- 调查揭示了EEA用于鞍区、鞍上及鞍旁疾病的地域和人口学趋势;尽管几乎所有国家均有EEA培训,但该入路用于巨大腺瘤、颅咽管瘤和脊索瘤的频率低于预期;经过20年的教育和推广,EEA的使用仍滞后,尤其是在发展中国家。
研究设计与样本
- 在线匿名且经过验证的结构化问卷调查研究,共收到261份回复,调查全球不同地区鞍区、鞍上及鞍旁病变管理中EEA、扩大EEA及眶周入路的使用情况。
主要发现
- 261名受访者中195人(74.71%)接受过EEA培训,但不足半数在住院医师期间接受培训。
- 108名受访者提到鞍旁病变占其过去5年实践中总病例的5%-25%。
- 仅一半受访者依赖耳鼻喉科同事完成入路。
- 欧洲和南美洲约一半时间依赖EEA,北美和亚洲仅三分之一时间使用EEA,非洲几乎不使用EEA。
- EEA用于超过50%的巨大垂体腺瘤、嗅沟脑膜瘤、颅咽管瘤、脊索瘤、鞍结节脑膜瘤和恶性颅底肿瘤病例的受访者比例分别为34.5%、3.4%、13%、16%、7%和10%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to understand the global trends in the proliferation of various minimal invasive approaches including the endonasal endoscopic approach (EEA) and the extended EEA. Questions about the use of the supraorbital and transorbital approach were also included. METHODS: We conducted an online anonymized and validated survey using a structured questionnaire on the use of EEA and EEEA, as well as periorbital approaches, in the management of sellar, suprasellar, and parasellar lesions in different parts of the world. RESULTS: A total of 261 responses were received. Of respondents, 195 (74.71%) received training in EEA, but less than half during residency. Of respondents, 108 mentioned that parasellar lesions comprised 5%-25% of the total cases encountered in the past 5 years in their practice. Only half of the respondents relied on ENT (ear, nose, and throat) colleagues for the approach. Whereas Europe and South America relied on EEA about half the time, North America and Asia used EEA only a third of the time; in Africa, EEA was hardly used at all. The proportion of respondents using EEA for >50% of giant pituitary adenoma, olfactory groove meningiomas, craniopharyngiomas, chordoma, tuberculum sella meningiomas, and malignant skull base tumors was 34.5%, 3.4%, 13%, 16%, 7%, and 10%, respectively. EEEA, the supraorbital approach, and the transorbital approach were used by 50.6%, 54.4%, and 34.5%, respectively. EEEA was used predominantly by those having an experience of 11-20 years or >30 years after residency (P = 0.018) and those from North America (64.1%). CONCLUSIONS: Our survey highlights the various geographic and demographic trends in the use of the EEA for sellar, suprasellar, and parasellar diseases. Although EEA training was present in almost all countries, the approach was not used as frequently as would have been expected for giant adenomas, craniopharyngiomas, and chordomas. After 20 years of education about the technique and indications of the endoscopic endonasal approach, through countless courses and publications, the use of EEA is still lagging, particularly in developing countries.
引用
- Garg K, Chaurasia B, Pahwa B, et al. Geographic Disparities in the Proliferation of Minimally Invasive Approaches for Sellar/Parasellar Lesions. World Neurosurg. 2022. PMID: 39499283. doi:10.1016/j.wneu.2022.09.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。